...
首页> 外文期刊>Biochemistry >1α,25-Dihydroxyvitamin D_3 Signaling Pathways on Calcium Uptake in 30-Day-Old Rat Sertoli Cells
【24h】

1α,25-Dihydroxyvitamin D_3 Signaling Pathways on Calcium Uptake in 30-Day-Old Rat Sertoli Cells

机译:1α,25-二羟基维生素D_3信号通路对30天大的大鼠支持细胞中钙摄取的影响

获取原文
获取原文并翻译 | 示例
           

摘要

1α,25-Dihydroxyvitamin D3_ (1,25D_3) is the active metabolite of vitamin D_3 and the major calcium regulatory hormone in tissues. The aim of this work was to investigate the mechanism of action of 1,25D_3 on 45Ca~(2+) uptake in Sertoli cells from 30-day-old rats. Results showed that 10~(-9) and 10~(-12) M 1,25D_3 increased the rate of 45Ca~(2+) uptake 5 and 15 min after hormone exposure and that 1α,25(OH)2 lumisterol3 (JN) produced a similar effect suggesting that 1,25D_3 action occurs via a putative membrane receptor. The involvement of voltage-dependent calcium channels (VDCC) in 1,25D_3 action was evidenced by using nifedipine, while the use of Bapta-AM demonstrated that intracellular calcium was not implicated. Moreover, the incubation with ouabain and digoxin increased the rate of ~(45)Ca~(2+) uptake, indicating that the effect of 1,25D_3 may also result from Na~+/K~+-ATPase inhibition. In addition, we demonstrated that the mechanism underlying the hormone action involved extracellular signal-regulated kinase (ERK) and protein kinase C (PKC) activation in a phospholipase C-independent way. Furthermore, a local elevation of the level of cAMP, as demonstrated by incubating cells with dibutyryl cAMP or a phosphodiesterase inhibitor, produced an effect similar to that of 1,25D_3, and the inhibition of protein kinase A (PKA) nullified the hormone action. In conclusion, the stimulatory effect of 1,25D_3 on 45Ca~(2+) uptake in Sertoli cells occurs via VDCC, as well as PKA, PKC, and ERK activation. These protein kinases seem to act by inhibiting Na~+/K~+-ATPase or directly osphorylating calcium channels. The Na~+/K~+-ATPase inhibition may result in Na~+/Ca~(2+) exchanger activation in reverse mode and consequently induce the uptake of calcium into the cells.
机译:1α,25-二羟基维生素D3_(1,25D_3)是维生素D_3的活性代谢产物,是组织中的主要钙调节激素。这项工作的目的是研究1,25D_3对30日龄大鼠Sertoli细胞45Ca〜(2+)摄取的作用机制。结果显示,在激素暴露后5和15分钟,10〜(-9)和10〜(-12)M 1,25D_3增加45Ca〜(2+)的摄取速率,而1α,25(OH)2 lumisterol3(JN )产生类似的作用,表明1,25D_3的作用是通过推定的膜受体发生的。硝苯地平证明了电压依赖性钙通道(VDCC)参与1,25D_3的作用,而Bapta-AM的使用表明不涉及细胞内钙。此外,与哇巴因和地高辛的孵育增加了〜(45)Ca〜(2+)的吸收速率,表明1,25D_3的作用也可能是由Na〜+ / K〜+ -ATPase抑制引起的。此外,我们证明了激素作用的潜在机制涉及以磷脂酶C独立的方式参与细胞外信号调节激酶(ERK)和蛋白激酶C(PKC)的激活。此外,通过将细胞与二丁酰基cAMP或磷酸二酯酶抑制剂一起孵育来证明,cAMP水平的局部升高产生了类似于1,25D_3的作用,并且蛋白激酶A(PKA)的抑制使激素作用无效。总之,1,2,5D_3对Sertoli细胞45Ca〜(2+)摄取的刺激作用是通过VDCC以及PKA,PKC和ERK激活产生的。这些蛋白激酶似乎是通过抑制Na〜+ / K〜+ -ATPase或直接磷酸化钙通道而起作用。 Na〜+ / K〜+ -ATPase的抑制作用可能导致Na〜+ / Ca〜(2+)交换子以相反的方式活化,从而诱导钙被细胞吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号